| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Catenin, beta interacting protein 1 (CTNNBIP1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412546 | 100 ug | ORIGENE TECHNOLOGIES |
| Catenin, beta like 1 (CTNNBL1) from ORIGENE TECHNOLOGIES | LY403090 | 100 ug | ORIGENE TECHNOLOGIES |
| Catenin, beta interacting protein 1 (CTNNBIP1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY423325 | 100 ug | ORIGENE TECHNOLOGIES |
| Catenin (cadherin-associated protein), alpha 2 (CTNNA2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY418015 | 100 ug | ORIGENE TECHNOLOGIES |
| Catenin (cadherin-associated protein), alpha 3 (CTNNA3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY415700 | 100 ug | ORIGENE TECHNOLOGIES |
| MZT2B - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN409713 | 1 kit | ORIGENE TECHNOLOGIES |
| MZT1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN412453 | 1 kit | ORIGENE TECHNOLOGIES |
| Mzt1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN510668 | 1 kit | ORIGENE TECHNOLOGIES |
| Mzt2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN510669 | 1 kit | ORIGENE TECHNOLOGIES |
| NAAA - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN218139 | 1 kit | ORIGENE TECHNOLOGIES |
| NAAA - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN218139LP | 1 kit | ORIGENE TECHNOLOGIES |
| NAAA - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN218139RB | 1 kit | ORIGENE TECHNOLOGIES |
| NAAA - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN418139 | 1 kit | ORIGENE TECHNOLOGIES |
| Naaa - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN510690 | 1 kit | ORIGENE TECHNOLOGIES |
| NAAA - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN218139BN | 1 kit | ORIGENE TECHNOLOGIES |
| MYST histone acetyltransferase 2 (MYST2) from ORIGENE TECHNOLOGIES | LY402089 | 100 ug | ORIGENE TECHNOLOGIES |
| MYST/Esa1-associated factor 6 (MEAF6) from ORIGENE TECHNOLOGIES | LY411575 | 100 ug | ORIGENE TECHNOLOGIES |
| Myt1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN510663 | 1 kit | ORIGENE TECHNOLOGIES |
| MYT1L - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN421586 | 1 kit | ORIGENE TECHNOLOGIES |
| Myt1l - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN510664 | 1 kit | ORIGENE TECHNOLOGIES |
| MYT1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN424321 | 1 kit | ORIGENE TECHNOLOGIES |
| Myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) (MX1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY428580 | 100 ug | ORIGENE TECHNOLOGIES |
| Myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) (MX1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY400886 | 100 ug | ORIGENE TECHNOLOGIES |
| Myxovirus (influenza virus) resistance 2 (mouse) (MX2) from ORIGENE TECHNOLOGIES | LY419297 | 100 ug | ORIGENE TECHNOLOGIES |
| Human defensin, alpha 1 (DEFA1) from ORIGENE TECHNOLOGIES | TP318421 | 20 ug | ORIGENE TECHNOLOGIES |
| Human defensin, alpha 1 (DEFA1). from ORIGENE TECHNOLOGIES | TP723336 | 20 ug | ORIGENE TECHNOLOGIES |
| Human defensin, alpha 5, Paneth cell-specific (DEFA5) from ORIGENE TECHNOLOGIES | TP310219 | 20 ug | ORIGENE TECHNOLOGIES |
| Human defensin, alpha 6, Paneth cell-specific (DEFA6) from ORIGENE TECHNOLOGIES | TP310229 | 20 ug | ORIGENE TECHNOLOGIES |
| Human defensin, beta 106A (DEFB106A) from ORIGENE TECHNOLOGIES | TP319477 | 20 ug | ORIGENE TECHNOLOGIES |
| Human defensin, beta 103A (DEFB103A). from ORIGENE TECHNOLOGIES | TP723033 | 20 ug | ORIGENE TECHNOLOGIES |
| Human defensin, beta 104A (DEFB104A). from ORIGENE TECHNOLOGIES | TP723034 | 20 ug | ORIGENE TECHNOLOGIES |
| Human defensin, beta 4A (DEFB4A). from ORIGENE TECHNOLOGIES | TP723032 | 20 ug | ORIGENE TECHNOLOGIES |
| Human degenerative spermatocyte homolog 1, lipid desaturase (Drosophila) (DEGS1), transcript variant 1 from ORIGENE TECHNOLOGIES | TP312803 | 20 ug | ORIGENE TECHNOLOGIES |
| Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS501089 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS501090 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS501091 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS501093 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS501092 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS501096 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS501380 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS502535 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS502536 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS501381 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS502537 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS502539 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS502652 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS502538 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS502671 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS503599 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS503601 | 5x5um | ORIGENE TECHNOLOGIES |